跳至主要内容
临床试验/CTRI/2017/08/009506
CTRI/2017/08/009506已完成3 期

Randomized double blind placebo controlled parallel trial to study the effect of ursodeoxycholic acid versus placebo in facilitating early hepatic clearance of radiotracer among patients undergoing 99mTc-sestamibi myocardial perfusion scintigraphy for detection of myocardial ischemia/ viability - UDCAMPS

Post Graduate Institute of Medical Education and Research0 个研究点目标入组 120 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • known or suspected coronary artery disease patients

排除标准

  • 1. Less than 18 years
  • 2.Patient not willing to give the consent
  • 3.Any patient with contraindication to use UDCA as interventional drug eg. gall stone disease, gall bladder inflammation, biliary tract occlusion, biliary colic and hypersenstivity to the drug etc.
  • 4.Patient with hepatic disorder affecting the tracer uptake
  • 5.Pregnant and lactating female patients

研究者

发起方
Post Graduate Institute of Medical Education and Research

相似试验